English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)
Chen, Jinzhang; Zang, Mengya; Pang, Huajin; Li, Chuanjiang; Zhao, Jianbo; Guo, Yabing; Hou, Jinlin
南方医科大学
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
2023-6-1
1
被引
10
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试